Teknova to Report Second Quarter 2025 Financial Results on August 7, 2025
Teknova (Nasdaq: TKNO), a producer of critical reagents for therapies, vaccines, and molecular diagnostics, has scheduled its Q2 2025 financial results announcement for August 7, 2025, after market close.
The company will host a conference call and webcast at 5 p.m. Eastern Time on the same day. Investors can access the webcast through Teknova's Investor Relations website, and participants wanting to join the call need to register to receive dial-in information. A replay will be available approximately two hours after the event.
Teknova (Nasdaq: TKNO), produttore di reagenti essenziali per terapie, vaccini e diagnostica molecolare, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 7 agosto 2025, dopo la chiusura del mercato.
La società terrà una conference call e webcast alle 17:00 ora della costa orientale nello stesso giorno. Gli investitori potranno accedere al webcast tramite il sito web delle Relazioni con gli Investitori di Teknova, mentre i partecipanti che desiderano prendere parte alla chiamata devono registrarsi per ricevere le informazioni per il collegamento telefonico. Una registrazione sarà disponibile circa due ore dopo l'evento.
Teknova (Nasdaq: TKNO), productor de reactivos críticos para terapias, vacunas y diagnóstico molecular, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 7 de agosto de 2025, tras el cierre del mercado.
La compañía realizará una llamada conferencia y webcast a las 5 p.m., hora del Este el mismo día. Los inversores podrán acceder al webcast a través del sitio web de Relaciones con Inversionistas de Teknova, y los participantes que deseen unirse a la llamada deben registrarse para recibir la información de acceso telefónico. Una repetición estará disponible aproximadamente dos horas después del evento.
Teknova (나스닥: TKNO)는 치료제, 백신 및 분자 진단용 핵심 시약 생산업체로, 2025년 2분기 재무실적 발표를 2025년 8월 7일 시장 마감 후로 예정했습니다.
회사는 같은 날 동부 표준시 기준 오후 5시에 컨퍼런스 콜 및 웹캐스트를 진행합니다. 투자자들은 Teknova 투자자 관계 웹사이트를 통해 웹캐스트에 접속할 수 있으며, 콜에 참여하려는 참가자는 전화 접속 정보를 받기 위해 등록해야 합니다. 이벤트 약 2시간 후 재청취가 가능합니다.
Teknova (Nasdaq : TKNO), producteur de réactifs essentiels pour les thérapies, vaccins et diagnostics moléculaires, a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le 7 août 2025, après la clôture des marchés.
L'entreprise organisera une conférence téléphonique et un webcast à 17h00 heure de l'Est le même jour. Les investisseurs pourront accéder au webcast via le site des relations investisseurs de Teknova, et les participants souhaitant rejoindre l'appel devront s'inscrire pour recevoir les informations de connexion. Une rediffusion sera disponible environ deux heures après l'événement.
Teknova (Nasdaq: TKNO), ein Hersteller wichtiger Reagenzien für Therapien, Impfstoffe und molekulare Diagnostik, hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für den 7. August 2025 nach Börsenschluss geplant.
Das Unternehmen wird am selben Tag eine Telefonkonferenz und Webcast um 17:00 Uhr Eastern Time abhalten. Investoren können über die Investor-Relations-Website von Teknova auf den Webcast zugreifen, und Teilnehmer, die an der Telefonkonferenz teilnehmen möchten, müssen sich registrieren, um die Einwahlinformationen zu erhalten. Eine Aufzeichnung wird etwa zwei Stunden nach der Veranstaltung verfügbar sein.
- None.
- None.
HOLLISTER, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2025, on Thursday, August 7, 2025, following the close of market.
Teknova will host a webcast and conference call on Thursday, August 7, 2025, beginning at 5 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this link. If you would like to participate in the call, please register for the webcast here to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in molecular diagnostics, synthetic biology, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture and cryopreservation media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies.
Investor Contact
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100
Media Contact
Jennifer Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259
This press release was published by a CLEAR® Verified individual.
FAQ
When will Teknova (TKNO) report Q2 2025 earnings?
What time is Teknova's Q2 2025 earnings call?
How can investors access Teknova's Q2 2025 earnings call?
Will there be a replay of Teknova's Q2 2025 earnings call?
